# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCor...
electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.31)...